Diabetes
Poster Session 3
Lee Reicher, MD (she/her/hers)
Resident
Lis Hospital for Women's Health, Tel Aviv Sourasky Medical Center
Tel-Aviv, Israel
Michal Rein, MSc
Weizmann Institute of Science
Rehovot, HaMerkaz, Israel
Nastya Godneva, MSc
Weizmann Institute of Science
Rehovot, HaMerkaz, Israel
Adina Weinberger, PhD
Weizmann Institute of Science
Rehovot, HaMerkaz, Israel
Yariv Yogev, MD
Lis Hospital for Women's Health, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, Israel
Eran Segal, PhD
Weizmann Institute of Science
Rehovot, HaMerkaz, Israel
Gestational diabetes mellitus (GDM) can be a risk factor for subsequent cardiovascular and metabolic diseases. However, there is a paucity of information regarding diverse cardiovascular, metabolic and multi-omic measurements in elderly women after GDM. We assessed the molecular and physiological profile of women with a history of GDM
Study Design:
Data collected as part of large-scale, prospective, longitudinal study with more than 10,000 healthy adults aged 40–70 years, between the years 2019 and 2022. The participants underwent physiological assessments through special medical tests and wearables, molecular profiling and collection of medical records and lifestyle questionnaires (Figure). We included women who reported at least one live birth and compared the profiles of women with a history of GDM to control subset, matched by the number of pregnancies and the time elapsed since the GDM pregnancy
Results:
Our study consisted of 300 and 800 women in GDM and the control group, respectively (mean of 17 years post-pregnancy). Women with a history of GDM displayed notable findings compared to the control group (*p< 0.001 for all)
GDM has long lasting effects on multiple physiological systems relating to metabolic syndrome. Insights provided can aid long-term monitoring and interventions to reduce cardiovascular and metabolic disease risks linked to GDM